Pliant Therapeutics, a Californian biopharma focused on discovering and developing fibrosis drugs, saw its shares close down ...
Pliant Therapeutics paused its phase 2b/3 trial of bexotegrast for idiopathic pulmonary fibrosis due to DSMB recommendations.
Pharmaceutical and Healthcare ecosystem driven by Blockchain.
12 天
GlobalData on MSNFDA gives RMAT designation to Beacon’s retinitis pigmentosa treatmentThe FDA has granted RMAT designation to Beacon Therapeutics’ gene therapy, laru-zova, for treating X-linked retinitis ...
SAP Integration Team Lead | Lead Software Engineer @ Beacon Pharma | Full Stack Mobile App Developer | Kotlin | KMP | KMM | Java | PHP | REST API | SAP SD Functions ...
It is unclear why an independent data safety monitoring board recommended the suspension of Pliant’s Phase IIb/III BEACON-IPF ...
Beacon MedTech Solutions recently announced that Phil Littlefield will serve as director of operations, effective immediately. With a track record of success in global manufacturing, ...
On Monday, Kay & Que (Bangladesh), a publicly listed company, was also downgraded to the Z category for the same reason.
The Lower Allen Township Police Department responded to reports of vehicle break-ins at the Beacon Hill Development in New ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果